Are “GABAergic” Agents Really So Selective for GABA? Implications for Single- versus Multi-Site Hypotheses From Promiscuous Behavior of Anesthetics and Their Molecular Targets In Vitro
Top Cited Papers
Open Access
- 23 January 2026
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 142 (6) , 1039-1049
Abstract
In the literature, anesthetic agents are commonly described as if their hypnotic action is mediated by a predominant molecular target, using terminology such as “GABAergic” or “NMDAergic.” The justification for this is unclear. The authors might thereby imply a single target hypothesis (ie, the named target is the sole or predominant molecular mechanism for that agent); or that in an in vitro dose-response plot, the potency or efficacy of this agent is distinctly (ie, several orders of magnitude) highest for interaction with the named target as compared with others. We explored if this last was the case, through review of data reported across 310 in vitro studies. We found that all but a few agents were highly “promiscuous,” influencing several different molecular targets with similar potency, making it difficult to justify that any one was predominant. Notably, propofol, often cited as a “typical GABAergic agent” in fact shows higher potency at nicotinic receptors and HCN ion channels than for GABA A receptors (GABA A Rs). Exceptions to promiscuity were, to an extent, etomidate and dexmedetomidine, which were relatively “monogomous” for GABA A R and α2-adrenoreceptors, respectively, and ketamine for NMDA receptors. Moreover, molecular targets were also promiscuous for which agents they were influenced by. This was in a manner that did not always correspond to the “preference” of an agent for a receptor. We discuss how this mutual promiscuity is consistent with a multi-site mechanism of anesthetic action.Keywords
This publication has 51 references indexed in Scilit:
- Anesthesia and the neurobiology of consciousnessNeuron, 2024
- Operations supported by ketamine anesthesia in resource-limited settings: Surgeons’ perceptions and recommendations – Qualitative StudyInternational Journal of Surgery Open, 2021
- Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitisEpilepsy & Behavior Reports, 2019
- The Benzodiazepine Binding Sites of GABAA ReceptorsTrends in Pharmacological Sciences, 2018
- Isoflurane disrupts excitatory neurotransmitter dynamics via inhibition of mitochondrial complex IBritish Journal of Anaesthesia, 2018
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeysEuropean Archives of Psychiatry and Clinical Neuroscience, 2016
- Identification and characterization of anesthetic targets by mouse molecular genetics approachesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2010
- Inhibition of human 5-HT3A and 5-HT3AB receptors by etomidate, propofol and pentobarbitalEuropean Journal of Pharmacology, 2007
- Emerging molecular mechanisms of general anesthetic actionTrends in Pharmacological Sciences, 2005
- Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the ratNeuropharmacology, 1992